AAAAAA

   
Results: 1-14 |
Results: 14
THE CLINICAL PREDICTIVITY OF BIOMARKERS OF STAGE III-IV EPITHELIAL OVARIAN-CANCER IN A PROSPECTIVE RANDOMIZED TREATMENT PROTOCOL
Authors: SILVESTRINI R DAIDONE MG VENERONI S BENINI E SCARFONE G ZANABONI F VILLA A PRESTI M DANESE S BOLIS G
Citation: R. Silvestrini et al., THE CLINICAL PREDICTIVITY OF BIOMARKERS OF STAGE III-IV EPITHELIAL OVARIAN-CANCER IN A PROSPECTIVE RANDOMIZED TREATMENT PROTOCOL, Cancer, 82(1), 1998, pp. 159-167
A PHASE I-II TRIAL OF FIXED-DOSE CARBOPLATIN AND ESCALATING PACLITAXEL IN ADVANCED OVARIAN-CANCER
Authors: BOLIS G SCARFONE G ZANABONI F VILLA A PRESTI M MELPIGNANO M FERRARIS C TATEO S GUARNERIO P GENTILE A PARAZZINI F
Citation: G. Bolis et al., A PHASE I-II TRIAL OF FIXED-DOSE CARBOPLATIN AND ESCALATING PACLITAXEL IN ADVANCED OVARIAN-CANCER, European journal of cancer, 33(4), 1997, pp. 592-595
WEEKLY CISPLATIN GIVEN FOR 2 MONTHS VERSUS CISPLATIN PLUS CYCLOPHOSPHAMIDE GIVEN FOR 5 MONTHS AFTER CYTOREDUCTIVE SURGERY FOR ADVANCED OVARIAN-CANCER
Authors: BOLIS G FAVALLI G DANESE S ZANABONI F MANGILI G SCARABELLI C TATEO S VALSECCHI MG SCARFONE G RICHIARDI G FRIGERIO I MELPIGNANO M VILLA A PARAZZINI F
Citation: G. Bolis et al., WEEKLY CISPLATIN GIVEN FOR 2 MONTHS VERSUS CISPLATIN PLUS CYCLOPHOSPHAMIDE GIVEN FOR 5 MONTHS AFTER CYTOREDUCTIVE SURGERY FOR ADVANCED OVARIAN-CANCER, Journal of clinical oncology, 15(5), 1997, pp. 1938-1944
NONCLOSURE OF PERITONEUM AT RADICAL ABDOMINAL HYSTERECTOMY AND PELVICNODE DISSECTION - A RANDOMIZED STUDY
Authors: FRANCHI M GHEZZI F ZANABONI F SCARABELLI C BERETTA P DONADELLO N
Citation: M. Franchi et al., NONCLOSURE OF PERITONEUM AT RADICAL ABDOMINAL HYSTERECTOMY AND PELVICNODE DISSECTION - A RANDOMIZED STUDY, Obstetrics and gynecology, 90(4), 1997, pp. 622-627
DETERMINANTS OF RESPONSE TO A CISPLATIN-BASED REGIMEN AS NEOADJUVANT CHEMOTHERAPY IN STAGE IB-IIB INVASIVE CERVICAL-CANCER
Authors: BOLIS G VANZAINTENPRZYBYSZ I SCARFONE G ZANABONI F SCARABELLI C TATEO S CALABRESE M PARAZZINI F
Citation: G. Bolis et al., DETERMINANTS OF RESPONSE TO A CISPLATIN-BASED REGIMEN AS NEOADJUVANT CHEMOTHERAPY IN STAGE IB-IIB INVASIVE CERVICAL-CANCER, Gynecologic oncology, 63(1), 1996, pp. 62-65
OCTREOTIDE IN THE MANAGEMENT OF BOWEL OBSTRUCTION IN TERMINAL OVARIAN-CANCER
Authors: MANGILI G FRANCHI M MARIANI A ZANABONI F RABAIOTTI E FRIGERIO L BOLIS PF FERRARI A
Citation: G. Mangili et al., OCTREOTIDE IN THE MANAGEMENT OF BOWEL OBSTRUCTION IN TERMINAL OVARIAN-CANCER, Gynecologic oncology, 61(3), 1996, pp. 345-348
SURVIVAL OF WOMEN WITH ADVANCED OVARIAN-CANCER AND COMPLETE PATHOLOGICAL RESPONSE AT 2ND-LOOK LAPAROTOMY
Authors: BOLIS G VILLA A GUARNERIO P FERRARIS C GAVONI N GIARDINA G MELPIGNANO M SCARFONE G ZANABONI F PARAZZINI F
Citation: G. Bolis et al., SURVIVAL OF WOMEN WITH ADVANCED OVARIAN-CANCER AND COMPLETE PATHOLOGICAL RESPONSE AT 2ND-LOOK LAPAROTOMY, Cancer, 77(1), 1996, pp. 128-131
MANAGEMENT OF ADNEXAL MASSES BY OPERATIVE LAPAROSCOPY
Authors: VANHERENDAEL B BERETTA P SLANGEN T FRANCHI M SWAEGERS M ZANABONI F
Citation: B. Vanherendael et al., MANAGEMENT OF ADNEXAL MASSES BY OPERATIVE LAPAROSCOPY, The Journal of the American Association of Gynecologic Laparoscopists, 2(3), 1995, pp. 273-277
ADJUVANT TREATMENT FOR EARLY EPITHELIAL OVARIAN-CANCER - RESULTS OF 2RANDOMIZED CLINICAL-TRIALS COMPARING CISPLATIN TO NO FURTHER TREATMENT OR CHROMIC PHOSPHATE (P-32)
Authors: BOLIS G COLOMBO N PECORELLI S TORRI V MARSONI S BONAZZI C CHIARI S FAVALLI G MANGILI C PRESTI M ZANABONI F MANGIONI C
Citation: G. Bolis et al., ADJUVANT TREATMENT FOR EARLY EPITHELIAL OVARIAN-CANCER - RESULTS OF 2RANDOMIZED CLINICAL-TRIALS COMPARING CISPLATIN TO NO FURTHER TREATMENT OR CHROMIC PHOSPHATE (P-32), Annals of oncology, 6(9), 1995, pp. 887-893
ORAL ONDANSETRON AND INTRAVENOUS DEXAMETHASONE IN THE PREVENTION OF CISPLATIN-INDUCED EMESIS
Authors: FRANCHI M DONADELLO N ZANABONI F TUSEI A SCORBATI E
Citation: M. Franchi et al., ORAL ONDANSETRON AND INTRAVENOUS DEXAMETHASONE IN THE PREVENTION OF CISPLATIN-INDUCED EMESIS, Oncology, 52(6), 1995, pp. 509-512
DIAGNOSIS OF PELVIC MASSES WITH TRANSABDOMINAL COLOR DOPPLER, CA-125 AND ULTRASONOGRAPHY
Authors: FRANCHI M BERETTA P GHEZZI F ZANABONI F GODDI A SALVATORE S
Citation: M. Franchi et al., DIAGNOSIS OF PELVIC MASSES WITH TRANSABDOMINAL COLOR DOPPLER, CA-125 AND ULTRASONOGRAPHY, Acta obstetricia et gynecologica Scandinavica, 74(9), 1995, pp. 734-739
DNA-PLOIDY AND PROLIFERATIVE ACTIVITY IN UTERINE-TUMORS - AN IN-VIVO STUDY USING BROMODEOXYURIDINE AND FLOW-CYTOMETRY
Authors: FRANCHINI G TUSEI A BABILONTI L DONADELLO N FRANCHI M ZANABONI F TATEO S MAZZINI G RICCARDI A DANOVA M
Citation: G. Franchini et al., DNA-PLOIDY AND PROLIFERATIVE ACTIVITY IN UTERINE-TUMORS - AN IN-VIVO STUDY USING BROMODEOXYURIDINE AND FLOW-CYTOMETRY, Oncology Reports, 1(1), 1994, pp. 65-67
RESPONSE TO 2ND-LINE WEEKLY CISPLATIN CHEMOTHERAPY IN OVARIAN-CANCER PREVIOUSLY TREATED WITH A CISPLATIN-BASED OR CARBOPLATIN-BASED REGIMEN
Authors: BOLIS G SCARFONE G LUCHINI L FERRARIS C ZANABONI F PRESTI M GIARDINA G VILLA A PARAZZINI F
Citation: G. Bolis et al., RESPONSE TO 2ND-LINE WEEKLY CISPLATIN CHEMOTHERAPY IN OVARIAN-CANCER PREVIOUSLY TREATED WITH A CISPLATIN-BASED OR CARBOPLATIN-BASED REGIMEN, European journal of cancer, 30A(12), 1994, pp. 1764-1768
HIGH-DOSE INTENSITY REGIMENS WITH EPIRUBICIN IN OVARIAN-CANCER
Authors: VERMORKEN JB BOLIS G VANRIJSWIJK REN KOBIERSKA A CHEVALLIER B VANDERBURG MEL ZANABONI F LENTZ MA BURGER CW KENEMANS P PINEDO HM
Citation: Jb. Vermorken et al., HIGH-DOSE INTENSITY REGIMENS WITH EPIRUBICIN IN OVARIAN-CANCER, Seminars in oncology, 21(1), 1994, pp. 17-22
Risultati: 1-14 |